Abrahams, J. P. et al., “The structure of bovine F-1-ATPase complexed with the peptide antibiotic efrapeptin,” Proceedings of the National Acad. of Sciences of the U.S., 93(18):9420-9424 (1996). |
Abrahams, J. P. et al., Biological Abstracts, abstract No. PREV199699198333, , Philadelphia, PA, US (1996) (Abstract). |
Matsuno-Yagi, A. et al., “Studies on the Mechanism of Oxidative Phosphorylation Effects of Specific F-0 Modifiers on Ligand-Induced Conformation Changes of F-1,” Proceedings of the National Acad. of Sciences of the U.S., 82(22) 7550-7554 (1985). |
Matsuno-Yagi, A. et al., Biological Abstracts, vol. 81, abstract No. 49500, Philadelphia, PA, US (1986) (Abstract). |
Murray, M. et al., “Antimicrobial testing using oxygen consumption as the indicator of susceptibility,” Archives of Pathology and Laboratory Medicine, 115(12)1235-1240 (1991). |
Murray, M. et al., Chemical Abstracts, vol. 117, No. 11, abstract No. 107719, Columbus, Ohio, US (Sep. 14, 1992) (Abstract). |
Georgopapadakou, N. H., et al. “Antifungal Agents: Chemotherapeutic Targets and Immunologic Strategies,” Antimicrobial Agents and Chemotherapy, 40 (2):279-291 (1996). |
Monk, B. C. et al., “Fungal Plasma Membrane Proton Pumps as Promising New Antifungal Targets,” Critical Reviews in Microbiology, 20(3):209-223 (1994). |
Portillo, F., et al., “Mode of Action of Miconazole on Yeasts: Inhibition of the Mitochondrial ATPase,” European Journal of Biochemistry, 143 (2):273-276 (1984). |
Odds, F. C. “Antifungal Agents and Their Use in Candida Infections,” In: Candida and Candidosis, Chapter 27, pp. 279-313 (1979). |